Ublituximab (Anti-CD20)
Ublituximab (Anti-CD20) is a chimeric recombinant IgG1 monoclonal antibody directed against human CD20 with potential antineoplastic activity. MW : 145.22 KD.
| Supplier | Selleck Chemicals |
|---|---|
| Product # | A2807 |
| Sku # | A2807-1mg*25 |
| Pricing | 1mg*25, $2970.00 |